Literature DB >> 8943366

Inhibition of nascent-peptide release at translation termination.

J Cao1, A P Geballe.   

Abstract

The transcript leader of the human cytomegalovirus (CMV) gpUL4 (gp48) gene contains a 22-codon upstream open reading frame (uORF2) that represses translation of the downstream cistron. Previous work demonstrated that ribosomes stall at the termination codon of uORF2 and, remarkably, that the coding information of uORF2 is required for both the translational repression and ribosomal stalling. We now provide evidence that the peptide product of uORF2 is synthesized and is retained in the ribosome in the form of a peptidyl-tRNA. Translation of the gp48 transcript leader in cell extracts produces the 2.4-kDa uORF2 peptide and a second product migrating with an apparent molecular mass of 20 kDa that represents the uORF2 peptide covalently linked to tRNA(Pro), the tRNA predicted to decode the carboxy-terminal codon of uORF2. The uORF2 peptidyl-tRNA is only detected after translation of RNAs containing uORF2 sequences that also inhibit downstream translation and cause ribosomal stalling. These data support a model in which the nascent uORF2 peptide blocks translation termination prior to hydrolysis of the peptidyl-tRNA bond. This blockade results in ribosomal stalling on the transcript leader which in turn impedes the access of ribosomes to the downstream cistron. This system illustrates that translation termination may be a critical step controlling expression of some eukaryotic genes.

Mesh:

Substances:

Year:  1996        PMID: 8943366      PMCID: PMC231714          DOI: 10.1128/MCB.16.12.7109

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  27 in total

1.  The primer tRNA for Moloney murine leukemia virus DNA synthesis. Nucleotide sequence and aminoacylation of tRNAPro.

Authors:  F Harada; G G Peters; J E Dahlberg
Journal:  J Biol Chem       Date:  1979-11-10       Impact factor: 5.157

Review 2.  Ribosome regulation by the nascent peptide.

Authors:  P S Lovett; E J Rogers
Journal:  Microbiol Rev       Date:  1996-06

3.  Translational regulation of SV40 early mRNA defines a new viral protein.

Authors:  K Khalili; J Brady; G Khoury
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

4.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.

Authors:  H Schägger; G von Jagow
Journal:  Anal Biochem       Date:  1987-11-01       Impact factor: 3.365

5.  Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system.

Authors:  J P Tam
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

6.  The leader peptide of yeast gene CPA1 is essential for the translational repression of its expression.

Authors:  M Werner; A Feller; F Messenguy; A Piérard
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

7.  Inhibition of the release factor-dependent termination reaction on ribosomes by DnaJ and the N-terminal peptide of rhodanese.

Authors:  W Kudlicki; O W Odom; G Merrill; G Kramer; B Hardesty
Journal:  J Bacteriol       Date:  1995-10       Impact factor: 3.490

8.  Role of an upstream open reading frame in mediating arginine-specific translational control in Neurospora crassa.

Authors:  Z Luo; M S Sachs
Journal:  J Bacteriol       Date:  1996-04       Impact factor: 3.490

9.  Ribosome pausing and stacking during translation of a eukaryotic mRNA.

Authors:  S L Wolin; P Walter
Journal:  EMBO J       Date:  1988-11       Impact factor: 11.598

Review 10.  The scanning model for translation: an update.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

View more
  39 in total

Review 1.  Translational control of viral gene expression in eukaryotes.

Authors:  M Gale; S L Tan; M G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

Review 2.  Upstream open reading frames as regulators of mRNA translation.

Authors:  D R Morris; A P Geballe
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  Termination and peptide release at the upstream open reading frame are required for downstream translation on synthetic shunt-competent mRNA leaders.

Authors:  M Hemmings-Mieszczak; T Hohn; T Preiss
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

4.  Abundant early expression of gpUL4 from a human cytomegalovirus mutant lacking a repressive upstream open reading frame.

Authors:  J P Alderete; S J Child; A P Geballe
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Activation of transcription of the human cytomegalovirus early UL4 promoter by the Ets transcription factor binding element.

Authors:  J Chen; M F Stinski
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  Rous sarcoma virus translation revisited: characterization of an internal ribosome entry segment in the 5' leader of the genomic RNA.

Authors:  C Deffaud; J L Darlix
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 7.  Control of eukaryotic protein synthesis by upstream open reading frames in the 5'-untranslated region of an mRNA.

Authors:  Hedda A Meijer; Adri A M Thomas
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

8.  Inhibition of translation termination mediated by an interaction of eukaryotic release factor 1 with a nascent peptidyl-tRNA.

Authors:  Deanna M Janzen; Lyudmila Frolova; Adam P Geballe
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

9.  Ribosomal features essential for tna operon induction: tryptophan binding at the peptidyl transferase center.

Authors:  Luis R Cruz-Vera; Aaron New; Catherine Squires; Charles Yanofsky
Journal:  J Bacteriol       Date:  2007-02-09       Impact factor: 3.490

10.  Forced evolution reveals the importance of short open reading frame A and secondary structure in the cauliflower mosaic virus 35S RNA leader.

Authors:  M M Pooggin; T Hohn; J Fütterer
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.